Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upexi (UPXI) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for Upexi (UPXI) over the last 6 years, with Q4 2025 value amounting to $1.6 million.

  • Upexi's Cash & Equivalents rose 29787.79% to $1.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 million, marking a year-over-year increase of 29787.79%. This contributed to the annual value of $3.0 million for FY2025, which is 34981.59% up from last year.
  • According to the latest figures from Q4 2025, Upexi's Cash & Equivalents is $1.6 million, which was up 29787.79% from $2.2 million recorded in Q3 2025.
  • Upexi's Cash & Equivalents' 5-year high stood at $14.5 million during Q2 2021, with a 5-year trough of $224318.0 in Q1 2024.
  • Its 5-year average for Cash & Equivalents is $3.6 million, with a median of $2.2 million in 2021.
  • In the last 5 years, Upexi's Cash & Equivalents surged by 246084.46% in 2021 and then tumbled by 8743.0% in 2023.
  • Upexi's Cash & Equivalents (Quarter) stood at $6.6 million in 2021, then crashed by 31.65% to $4.5 million in 2022, then tumbled by 87.43% to $566677.0 in 2023, then fell by 28.29% to $406347.0 in 2024, then skyrocketed by 297.88% to $1.6 million in 2025.
  • Its Cash & Equivalents stands at $1.6 million for Q4 2025, versus $2.2 million for Q3 2025 and $3.0 million for Q2 2025.